2017-2022 Japan RNAi for Therapeutic Market Report (Status and Outlook)

May 2017 | 115 pages | ID: 244420AD87DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The RNAi for Therapeutic market size will be XX million (USD) in 2022 in Japan, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.

In Japan market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as

• Alnylam Pharmaceuticals
• Arrowhead
• Dicerna Pharmaceuticals
• Mirna Therapeutics
• Quark Pharmaceuticals
• RXi Pharmaceuticals
• miRagen Therapeutics
• Gradalis
• Sirnaomics

Split by product types/category, covering many types. with sales, revenue and market share for each type, such as

• siRNA
• miRNA
• shRNA

Split by applications/end use industries, covers many application. This report focuses on sales, market share and growth rate of RNAi for Therapeutic in each application.suach as

• Cancer
• Cardiovascular
• HBV
• Other

Contents

1 RNAI FOR THERAPEUTIC MARKET OVERVIEW

1.1 Product Overview and Scope of RNAi for Therapeutic
1.2 RNAi for Therapeutic Market Segment by Types
  1.2.1 Japan RNAi for Therapeutic Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 Japan RNAi for Therapeutic Sales Market Share by Types in 2016
  1.2.3 siRNA
  1.2.4 miRNA
shRNA
1.3 Japan RNAi for Therapeutic Market Segment by Applications/End Use Industries
  1.3.1 Japan RNAi for Therapeutic Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 Japan RNAi for Therapeutic Sales Market Share by Types in 2016
  1.3.3 Cancer
  1.3.4 Cardiovascular
  1.3.5 HBV
Other
1.4 Japan RNAi for Therapeutic Overview and Market Size (Value) (2012-2022)
  1.4.1 Japan Market RNAi for Therapeutic Overview
  1.4.2 Japan RNAi for Therapeutic Market Size (Value and Volume) Status and Forecast (2012-2022)

2 JAPAN RNAI FOR THERAPEUTIC SALES, REVENUE (VALUE) AND MARKET SHARE BY VENDORS/MANUFACTURERS

2.1 Japan RNAi for Therapeutic Sales and Market Share (2012-2017) by Vendors/Manufacturers
2.2 Japan RNAi for Therapeutic Revenue and Market Share by Vendors (2012-2017)
2.3 Japan RNAi for Therapeutic Average Price by Vendors in 2016
2.4 Japan RNAi for Therapeutic Manufacturing Base Distribution, Sales Area, Product Types by Vendors
2.5 RNAi for Therapeutic Market Competitive Situation and Trends
  2.5.1 RNAi for Therapeutic Market Concentration Rate
  2.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 5 Vendors
  2.5.3 Mergers & Acquisitions, Expansion

3 JAPAN RNAI FOR THERAPEUTIC SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 Japan RNAi for Therapeutic Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 Japan RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
  3.1.2 Japan RNAi for Therapeutic Revenue and Market Share by Type (2012-2017)
  3.1.3 Japan RNAi for Therapeutic Price by Type (2012-2017)
3.2 Japan RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
3.3 Japan Market RNAi for Therapeutic Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 JAPAN RNAI FOR THERAPEUTIC VENDORS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Alnylam Pharmaceuticals
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 RNAi for Therapeutic Product Types, Application and Specification
    4.1.2.1 Category One
    4.1.2.2 Category Two
  4.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.1.4 Main Business/Business Overview
  4.1.5 Alnylam Pharmaceuticals News
4.2 Arrowhead
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 RNAi for Therapeutic Product Types, Application and Specification
    4.2.2.1 Category One
    4.2.2.2 Category Two
  4.2.3 Arrowhead RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.2.4 Main Business/Business Overview
  4.2.5 Arrowhead News
4.3 Dicerna Pharmaceuticals
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 RNAi for Therapeutic Product Types, Application and Specification
    4.3.2.1 Category One
    4.3.2.2 Category Two
  4.3.3 Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.3.4 Main Business/Business Overview
  4.3.5 Dicerna Pharmaceuticals News
4.4 Mirna Therapeutics
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 RNAi for Therapeutic Product Types, Application and Specification
    4.4.2.1 Category One
    4.4.2.2 Category Two
  4.4.3 Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.4.4 Main Business/Business Overview
  4.4.5 Mirna Therapeutics News
4.5 Quark Pharmaceuticals
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 RNAi for Therapeutic Product Types, Application and Specification
    4.5.2.1 Category One
    4.5.2.2 Category Two
  4.5.3 Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.5.4 Main Business/Business Overview
  4.5.5 Quark Pharmaceuticals News
4.6 RXi Pharmaceuticals
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 RNAi for Therapeutic Product Types, Application and Specification
    4.6.2.1 Category One
    4.6.2.2 Category Two
  4.6.3 RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.6.4 Main Business/Business Overview
  4.6.5 RXi Pharmaceuticals News
4.7 miRagen Therapeutics
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 RNAi for Therapeutic Product Types, Application and Specification
    4.7.2.1 Category One
    4.7.2.2 Category Two
  4.7.3 miRagen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.7.4 Main Business/Business Overview
  4.7.5 miRagen Therapeutics News
4.8 Gradalis
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 RNAi for Therapeutic Product Types, Application and Specification
    4.8.2.1 Category One
    4.8.2.2 Category Two
  4.8.3 Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.8.4 Main Business/Business Overview
  4.8.5 Gradalis News
4.9 Sirnaomics
  4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.9.2 RNAi for Therapeutic Product Types, Application and Specification
    4.9.2.1 Category One
    4.9.2.2 Category Two
  4.9.3 Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.9.4 Main Business/Business Overview
  4.9.5 Sirnaomics News

5 PRODUCTION COST ANALYSIS OF RNAI FOR THERAPEUTIC

5.1 Main Raw Materials of RNAi for Therapeutic
  5.1.1 List of RNAi for Therapeutic Main Raw Materials
  5.1.2 RNAi for Therapeutic Main Raw Materials Price Analysis
  5.1.3 RNAi for Therapeutic Raw Materials Major Suppliers
  5.1.4 RNAi for Therapeutic Main Raw Materials Market Concentration Rate
5.2 Production Cost Structure of RNAi for Therapeutic
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Production Expenses
5.3 RNAi for Therapeutic Manufacturing Process/Method

6 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

6.1 RNAi for Therapeutic Value Chain Analysis
6.2 Upstream Raw Materials Purchasing
6.3 Raw Materials Sources of RNAi for Therapeutic Major Vendors in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Sales Channel
  7.1.1 Direct Sales
  7.1.2 Indirect Sales
  7.1.3 Sales Channel Development Trend
7.2 Product Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 RNAi for Therapeutic Distributors/Traders List in Japan

8 MARKET INFLUENCES FACTORS ANALYSIS

8.1 Changes from the Related Industries
8.2 Substitutes Threat
8.3 Customer Preference Change
8.4 Economic/Political Environmental Change
8.5 Upstream and Downstream Fluctuation

9 JAPAN RNAI FOR THERAPEUTIC MARKET FORECAST (2017-2022)

9.1 Japan RNAi for Therapeutic Sales, Revenue and Price Forecast (2017-2022)
  9.1.1 Japan RNAi for Therapeutic Sales and Growth Rate Forecast (2017-2022)
  9.1.2 Japan RNAi for Therapeutic Revenue and Growth Rate Forecast (2017-2022)
  9.1.3 Japan RNAi for Therapeutic Price Trend Forecast (2017-2022)
9.2 Japan RNAi for Therapeutic Sales Forecast by Type (2017-2022)
9.3 Japan RNAi for Therapeutic Sales Forecast by Application (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Analyst Introduction
11.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of RNAi for Therapeutic
Figure Japan RNAi for Therapeutic Sales (volume) for Each Type (2012-2022)
Figure Japan RNAi for Therapeutic Sales Market Share by Types in 2016
Figure Product Picture of siRNA
Table Major Players of siRNA
Figure Product Picture of miRNA
Table Major Players of miRNA
Figure Product Picture of shRNA
Table Major Players of shRNA
Figure Japan RNAi for Therapeutic Sales Present Situation and Outlook by Applications (2012-2022)
Figure Japan RNAi for Therapeutic Sales Market Share by Types in 2016
Figure Cancer Examples
Figure Cardiovascular Examples
Figure HBV Examples
Figure Other Examples
Figure Japan RNAi for Therapeutic Revenue (Million USD) Status and Forecast (2012-2022)
Figure Japan RNAi for Therapeutic Sales (Volume) Status and Forecast (2012-2022)
Table Japan RNAi for Therapeutic Sales by Vendors (2012-2017)
Table Japan RNAi for Therapeutic Sales Market Share (%) by Vendors (2012-2017)
Figure Japan RNAi for Therapeutic Sales Share by Vendors in 2015
Figure Japan RNAi for Therapeutic Sales Share by Vendors in 2016
Table Japan RNAi for Therapeutic Revenue (Million USD) by Vendors (2012-2017)
Table Japan RNAi for Therapeutic Revenue Market Share (%) by Vendors (2012-2017)
Figure Japan RNAi for Therapeutic Revenue Share by Vendors in 2015
Figure Japan RNAi for Therapeutic Revenue Share by Vendors in 2016
Table Japan RNAi for Therapeutic Average Price by Vendors in 2016
Table Japan RNAi for Therapeutic Manufacturing Base Distribution and Sales Area by Vendors
Table Vendors RNAi for Therapeutic Product Types
Figure RNAi for Therapeutic Market Share of Top 3 Vendors
Figure RNAi for Therapeutic Market Share of Top 5 Vendors
Table Japan RNAi for Therapeutic Sales by Type (2012-2017)
Table Japan RNAi for Therapeutic Sales and Market Share by Type (2012-2017)
Figure Japan RNAi for Therapeutic Sales Market Share by Type (2012-2017)
Figure 2016 Japan RNAi for Therapeutic Sales Market Share by Type
Table Japan RNAi for Therapeutic Revenue (Million USD) by Type (2012-2017)
Table Japan RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure Japan RNAi for Therapeutic Revenue Market Share by Type (2012-2017)
Figure 2016 Japan RNAi for Therapeutic Revenue Market Share by Type
Table Japan RNAi for Therapeutic Price by Type (2012-2017)
Table Japan RNAi for Therapeutic Sales by Application (2012-2017)
Table Japan RNAi for Therapeutic Sales and Market Share by Application (2012-2017)
Figure Japan RNAi for Therapeutic Sales Market Share by Application (2012-2017)
Figure 2016 Japan RNAi for Therapeutic Sales Market Share by Application
Table Japan Market RNAi for Therapeutic Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table Arrowhead Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arrowhead RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Arrowhead RNAi for Therapeutic Market Share (2012-2017)
Table Dicerna Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dicerna Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table Mirna Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mirna Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2012-2017)
Table Quark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Quark Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table RXi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table RXi Pharmaceuticals RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2012-2017)
Table miRagen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table miRagen Therapeutics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure miRagen Therapeutics RNAi for Therapeutic Market Share (2012-2017)
Table Gradalis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Gradalis RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gradalis RNAi for Therapeutic Market Share (2012-2017)
Table Sirnaomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sirnaomics RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sirnaomics RNAi for Therapeutic Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure RNAi for Therapeutic Main Raw Materials Price Trend
Table RNAi for Therapeutic Raw Materials Major Suppliers List
Figure Production Cost Structure of RNAi for Therapeutic
Figure RNAi for Therapeutic Manufacturing Process/Method
Figure RNAi for Therapeutic Value Chain Analysis
Table Raw Materials Sources of RNAi for Therapeutic Major Vendors in 2016
Table Major Buyers of RNAi for Therapeutic
Table RNAi for Therapeutic Distributors/Traders List in Japan
Figure Japan RNAi for Therapeutic Sales and Growth Rate Forecast (2017-2022)
Figure Japan RNAi for Therapeutic Revenue and Growth Rate Forecast (2017-2022)
Figure Japan RNAi for Therapeutic Price Trend Forecast (2017-2022)
Table Japan RNAi for Therapeutic Sales Forecast by Type (2017-2022)
Figure Japan RNAi for Therapeutic Sales Market Share Forecast by Type (2017-2022)
Figure Japan RNAi for Therapeutic Sales Market Share Forecast by Type in 2022
Table Japan RNAi for Therapeutic Sales Forecast by Application (2017-2022)
Figure Japan RNAi for Therapeutic Sales Market Share Forecast by Application (2017-2022)
Figure Japan RNAi for Therapeutic Sales Market Share Forecast by Application in 2022